Previous 10 | Next 10 |
Cognyte Software (CGNT) -23% on Q1 earnings release. Acutus Medical (AFIB) -9%. Benitec Biopharma (BNTC) -9%. Fujian Blue Hat Interactive Entertainment Technology (BHAT) -8%. ToughBuilt Industries (TBLT) -6%. NeuroSense Therapeutics (NRSN) -6%. For further details see: Cognyte...
Borqs Technologies (BRQS) -25% after announcing 1-for-16 reverse stock split. Benitec Biopharma (BNTC) -13%. ToughBuilt Industries (TBLT) -14%. Chimerix (CMRX) -10% Monkeypox plays are lower as WHO rules out emergency status. Fujian Blue Hat Interactive Entertainment Techn...
There’s only one week left until we turn the page on June and the second quarter. With GDP numbers and more CPI data expected to show the progress in curbing inflation, the market’s risk appetite seems to change daily. But one of the more static trends in the stock market toda...
Benitec press release (NASDAQ:BNTC): Q3 GAAP EPS of -$0.40 beats by $0.04. Revenue of $0.48M. For further details see: Benitec GAAP EPS of -$0.40 beats by $0.04, revenue of $0.48M
HAYWARD, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA int...
Benitec press release (NASDAQ:BNTC): FQ2 GAAP EPS of -$0.59. Revenue of $25K. For further details see: Benitec GAAP EPS of -$0.59, revenue of $25K
Benitec Biopharma Discloses Q2 2022 Financial Results PR Newswire HAYWARD, Calif. , Feb. 14, 2022 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing ...
Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Ener...
Benitec Biopharma Discloses Q1 2022 Financial Results PR Newswire HAYWARD, Calif. , Nov. 15, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing n...
Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif. , Sept. 20, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene t...
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
Benitec Biopharma Limited Website:
2024-07-16 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the 180-day post-dose assessment following the administration of the low dose of gene therapy BB-301 as ...
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace ...